Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97134495 | 9713449 | 5 | F | 20120912 | 20160913 | 20131126 | 20160923 | EXP | US-ELI_LILLY_AND_COMPANY-US201209006114 | ELI LILLY AND CO | 56.27 | YR | F | Y | 0.00000 | 20160923 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97134495 | 9713449 | 1 | PS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | Y | U | C010343C | 21318 | 20 | UG | INJECTION | QD | |||
| 97134495 | 9713449 | 2 | SS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | Y | U | 21318 | 20 | UG | INJECTION | QD | ||||
| 97134495 | 9713449 | 3 | SS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | Y | U | C072210F | 21318 | 20 | UG | INJECTION | QD | |||
| 97134495 | 9713449 | 4 | SS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QD | Y | U | 21318 | 20 | UG | INJECTION | QD | ||||
| 97134495 | 9713449 | 5 | SS | FORTEO | TERIPARATIDE | 1 | Unknown | 20 UG, QOD | Y | U | C470472G | 21318 | 20 | UG | INJECTION | QOD | |||
| 97134495 | 9713449 | 6 | SS | FORTEO | TERIPARATIDE | 1 | 20 UG, QD | Y | U | 21318 | 20 | UG | INJECTION | QD | |||||
| 97134495 | 9713449 | 7 | SS | EVISTA | RALOXIFENE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | Y | U | 0 | 60 | MG | TABLET | QD | ||||
| 97134495 | 9713449 | 8 | SS | EVISTA | RALOXIFENE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | Y | U | 0 | 60 | MG | TABLET | QD | ||||
| 97134495 | 9713449 | 9 | SS | XARELTO | RIVAROXABAN | 1 | Unknown | UNK UNK, UNKNOWN | 0 | ||||||||||
| 97134495 | 9713449 | 10 | C | CALTRATE | CALCIUM CARBONATE | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97134495 | 9713449 | 1 | Osteoporosis |
| 97134495 | 9713449 | 2 | Bone density decreased |
| 97134495 | 9713449 | 7 | Osteoporosis |
| 97134495 | 9713449 | 9 | Thrombosis |
| 97134495 | 9713449 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97134495 | 9713449 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97134495 | 9713449 | Apathy | |
| 97134495 | 9713449 | Arthralgia | |
| 97134495 | 9713449 | Asthenia | |
| 97134495 | 9713449 | Blood calcium increased | |
| 97134495 | 9713449 | Bone density decreased | |
| 97134495 | 9713449 | Breast disorder | |
| 97134495 | 9713449 | Contusion | |
| 97134495 | 9713449 | Dizziness | |
| 97134495 | 9713449 | Eating disorder | |
| 97134495 | 9713449 | Headache | |
| 97134495 | 9713449 | Hypoaesthesia | |
| 97134495 | 9713449 | Incorrect drug administration duration | |
| 97134495 | 9713449 | Injection site bruising | |
| 97134495 | 9713449 | Mood altered | |
| 97134495 | 9713449 | Muscle spasms | |
| 97134495 | 9713449 | Nausea | |
| 97134495 | 9713449 | Pain in extremity | |
| 97134495 | 9713449 | Palpitations | |
| 97134495 | 9713449 | Restless legs syndrome | |
| 97134495 | 9713449 | Road traffic accident | |
| 97134495 | 9713449 | Sluggishness | |
| 97134495 | 9713449 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 97134495 | 9713449 | 1 | 20120908 | 201209 | 0 | |
| 97134495 | 9713449 | 4 | 20130519 | 0 | ||
| 97134495 | 9713449 | 5 | 20160812 | 0 | ||
| 97134495 | 9713449 | 7 | 2009 | 0 |